Christopher Kirk
2017
In 2017, Christopher Kirk earned a total compensation of $745.3K as President and Chief Scientific Officer at Kezar Life Sciences.
Compensation breakdown
| Non-Equity Incentive Plan | $111,000 |
|---|---|
| Option Awards | $298,476 |
| Salary | $325,000 |
| Other | $10,800 |
| Total | $745,276 |
Kirk received $325K in salary, accounting for 44% of the total pay in 2017.
Kirk also received $111K in non-equity incentive plan, $298.5K in option awards and $10.8K in other compensation.
Rankings
In 2017, Christopher Kirk's compensation ranked 10,332nd out of 14,666 executives tracked by ExecPay. In other words, Kirk earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,332 out of 14,666 | 30th |
Division Manufacturing | 4,008 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,414 out of 2,075 | 32nd |
Industry group Drugs | 1,150 out of 1,731 | 34th |
Industry Pharmaceutical Preparations | 898 out of 1,333 | 33rd |
Source: SEC filing on April 30, 2019.
Kirk's colleagues
We found one more compensation record of an executive who worked with Christopher Kirk at Kezar Life Sciences in 2017.
2017
John Fowler
Kezar Life Sciences